Rituximab (MabThera®, Rituxan®) is a chimaeric murine/human antibody targeted against the surface antigen CD20 that is expressed on normal and malignant human mature B cells, but not stem cells or plasma cells. It is potentially the proverbial magic bullet for diseases associated with B cell disorders as well as a probe for elucidating the role of B cells in health and disease. This book explores the full spectrum of activity of Rituximab in man.
| ISBN: | 9781622575336 |
| Publication date: | 25th January 2013 |
| Author: | G V LakeBakaar |
| Publisher: | Nova Science Publishers an imprint of Nova Science Publishers Inc |
| Format: | Paperback |
| Pagination: | 147 pages |
| Series: | Pharmacology - Research, Safety Testing and Regulation |
| Genres: |
Pharmacology |